SEEK   Report issue

For profit Phase 1 Phase 2
Founded: London United Kingdom (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2009
NCT01071031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

PepTcell Limited | SEEK

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 1)

HIV Infections (Phase 1)

Infections (Phase 1)

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 7